Skip to content
All posts

Labquality expands its clinical trial services to pharmaceuticals in Germany

An image stating

Labquality Corporation acquires P.R.I.S.M.A.-CRO GmbH.

P.R.I.S.M.A.-CRO is a German company specialising in clinical trial services for the pharmaceutical and biotech industries. P.R.I.S.M.A. and its experienced professionals further strengthen Labquality’s clinical trial offering in the pharmaceutical and biotech markets. The acquisition is in line with Labquality’s strategy to build an international full-service contract research organization (CRO).

The acquisition of P.R.I.S.M.A. enables Labquality to grow its CRO business in the German and Central European pharmaceutical markets.

“P.R.I.S.M.A. fits perfectly into our Labquality family and it complements our growing CRO business. P.R.I.S.M.A. enables us to enter the German pharmaceutical markets and increases our capability to offer multi-site clinical trial services in Central Europe. Additionally, P.R.I.S.M.A. provides us with experience and competence of making end-to-end regulatory submissions to the German Competent Authorities and Ethics Committees,” says CEO Juha-Pekka Nuutinen from Labquality.

“As the CRO market becomes increasingly competitive, the CRO companies need to build larger foundations for their operations. Joining forces with a bigger company like Labquality enables us to operate more competitively in the future. Labquality has an established and highly valued quality culture, and they also bring us the opportunity to have GDPR experts and full data management operations in-house. Together we can meet the challenges of the market and offer first-class CRO services to our customers,” concludes Dirk Strickmann, the founder and CEO of P.R.I.S.M.A.

The acquisition strengthens Labquality’s position as a CRO service provider for the pharmaceutical and health technology industries.

The acquisition does not have any impact on the current customer relationships, partnerships, or personnel of P.R.I.S.M.A. or Labquality.

For queries, please contact:

Juha-Pekka Nuutinen
CEO | Labquality Oy
+358 40 828 3210 |

Dirk Strickmann


+49 (0)2173-10947-13 |

Share this article

Subscribe to our newsletter

Subscribe to hear the latest news in the industry and keep track of what's happening behind the scenes.